73 results
Page 3 of 4
8-K
EX-99.1
oq5vat0xc8z277odet55
6 May 21
CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer
4:24pm
DEF 14A
qv2ol
22 Apr 21
Definitive proxy
12:35pm
10-K
cz37 es22
25 Mar 21
Annual report
12:00am
8-K
yjeygw3
13 Jan 21
Departure of Directors or Certain Officers
12:58pm
8-K
EX-10.1
w9dblp93x ek4b
13 Jan 21
Departure of Directors or Certain Officers
12:58pm
8-K
EX-10.1
s92 d1w4jf
5 Oct 20
Nkarta Announces Leadership Changes
4:15pm
8-K
daxacn8 e7betfsh
5 Oct 20
Nkarta Announces Leadership Changes
4:15pm
10-Q
zboj5
20 Aug 20
Quarterly report
4:51pm
10-Q
EX-10.5
7joar5yi9 pp4xiaoxbs
20 Aug 20
Quarterly report
4:51pm
10-Q
EX-10.6
pjv m160w
20 Aug 20
Quarterly report
4:51pm
424B4
8eo9c xuuaggbbpo
10 Jul 20
Prospectus supplement with pricing info
9:35pm
S-1/A
EX-1.1
ma5 5e9gn4
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
EX-10.5
b0ho e3jocpenias
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
EX-10.4
3nblxgtmy6akvo
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
EX-10.1
kmmkep7mppyp av24b
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
4r7dz8i2tggdix73o9
2 Jul 20
IPO registration (amended)
5:17pm
S-1
gmna7x e3zhl
19 Jun 20
IPO registration
3:24pm